Faisal Riaz | Medical Director Neuroimmunology and AATD
Takeda Pharmaceuticals USA Inc

Faisal Riaz is a dedicated and accomplished Medical Director specializing in Neuroimmunology and Alpha-1 Antitrypsin Deficiency (AATD) at Takeda Pharmaceuticals USA Inc. With a strong background in medicine and a passion for rare diseases, Faisal brings extensive experience in the field of orphan drugs and rare diseases to his role. As a former clinician, Faisal strives to amplify the voices of patients and their families. 

Having worked in various capacities within the pharmaceutical industry, Faisal has a deep understanding of the complexities involved in developing treatments for rare diseases. His expertise in neuroimmunology and AATD allows him to drive innovative strategies for drug development and patient care, ultimately making a meaningful impact on the lives of those affected by these conditions.

Faisal is known for his collaborative approach, working closely with cross-functional teams to advance research, clinical trials, and regulatory processes. His commitment to improving patient outcomes and advocating for those with rare diseases is evident in his work and leadership within the industry.

As a speaker at the World Orphan Drug Congress USA 2025, Faisal will share his insights and expertise on the latest advancements in orphan drug development and rare disease management. Attendees can expect to gain valuable knowledge from Faisal's presentation, informed by his years of experience and dedication to making a difference in the rare disease community.